Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York based President operating in the Health Care space. If you think a President is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Raj Krishnan
Vice President Of Product Management of Noom
Raj Krishnan is VP Product at Noom
Follow Raj Krishnan:
About Noom: Noom is a psychology-based digital health platform used to provide intelligent nutrition and exercise coaching.
_______
Mark Morris
Vice-President of Research and Development of Elysium
Mark Morris, Elysium Health vice president of research and development, is passionate about bringing an open source model to clinical research in an effort to accelerate advances in human health. By increasing the transparency in scientific research and developing partnerships, a multi-discipline approach may not only fast-track discovery but also lead to a more complete understanding of health issues and more effective treatments. In his role at Elysium, he is responsible for the clinical research program, product development, and commercialization of proprietary technologies. One area of particular interest is the synergy between NAD+ modulation and sirtuin activation, which can be beneficial for a wide range of therapeutic areas. Morris has fifteen years of experience developing new technologies in various industries and has received several patents throughout his career. He has a B.S. in chemical engineering from the University of Akron and resides in New York City.
Follow Mark Morris:
About Elysium: Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
Stephen Barat
Associate Vice President, Non-Clinical Development of Allergan
Stephen Barat is currently the Executive Director of Non-clinical and Translational Sciences – Safety Assessment and Bioanalysis for Allergan. He has 20 years of experience in global drug development and registration, with a specific interest in drug device combinations, the interface of safety assessment and CMC requirements, and extensive experience in the safety assessment of impurities. Dr. Barat is a member of the PQRI – PDP working group and toxicology sub-team as well as the USP Expert Panel for Biocompatability of Packaging Materials.
Follow Stephen Barat:
About Allergan, The Janssen Pharmaceutical Companies of Johnson & Johnson: Allergan is a global pharmaceutical company.
Jeffrey Schwartz
Executive Vice President of Sales of Drive Medical
Jeffrey Schwartz is a principal founder of Drive medical. Jeffrey served as the Vice President of Sales of Diamond Medical and National Healthcare from 1987 until 1992. Following the sale to a publicly traded healthcare company, Jeffrey served as the Vice President of Sales of such public company until 1996. In 1996, Jeffrey formed Jofra Enterprises, Inc., a distributor of medical products, located in Mt. Vernon, New York, which was subsequently acquired by a publicly traded healthcare company in 1998. Jeffrey served as the Executive Vice President of Sales of the publicly traded healthcare company from 1998 through 2000.
Follow Jeffrey Schwartz:
About Drive Medical, Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Vidya Raman-Tangella
Senior Vice President, and Head, UHC Innovation Center of Excellence of UnitedHealth Group
Vidya Raman-Tangella is leading innovation at the country’s largest health care company, helping people live healthier lives through an ongoing transformation of the health care system. Raman-Tangella heads UnitedHealthcare’s Innovation Center of Excellence, developing breakthroughs with practical solutions for improving health care quality, access and affordability. UnitedHealthcare is a subsidiary of UnitedHealth Group, which serves more than 132 million people worldwide. A physician-innovator with more than 20 years of experience in the health field, Raman-Tangella collaborates with diverse partners to develop simpler, more intelligent, and cost effective health care solutions. Her colleagues say she is exceptional with designing ecosystems that drive change in the health care market through the use of data and technology. Raman-Tangella and her team design, develop and scale breakthrough innovations that help address unmet health needs with holistic solutions. They use Human-Centered Design, outside-in thinking, and co-creation models to create meaningful solutions that deliver lasting value. Deep partnerships internally and strategic partnerships externally enable the team to create multi-faceted, holistic solutions. As a senior healthcare leader with a passion for personalized health journeys, she previously held an executive role at Johnson & Johnson, where she led the design of integrated and tailored health and wellness solutions for employers and health care plans. She was instrumental in the company’s start-up organization, providing expertise about strategic partnerships and enterprise integration. “My biggest career leap was entering the world of innovation from a world of clinical medicine,” Raman-Tangella said. “I have since learned that it is possible to have the best of both these worlds, and my daily quest is to find ways to pursue them both. This for me has resulted in a deep passion for the world of personalized health, medicine and health care.” She also says being a woman in her profession is fulfilling and fascinating. “I think women are inherently great at innovation, given their ability to think and apply multiple facets and look beyond the here and now,” she explained. Raman-Tangella’s desire to address unmet health care issues has led to the development and launch of several innovations, including the Baby Block program, a free online and mobile healthy-baby initiative. Another of her innovations is Solutions for Caregivers, a program for large employers featuring in-person, telephonic, and online resources designed to help caregivers save money and more effectively provide assistance to the people they support. Raman-Tangella holds a bachelor’s of medicine and a bachelor’s of surgery from Osmania University in India, and a master’s of health administration from Cornell University.
Follow Vidya Raman-Tangella:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Ben Wiegand
Senior Vice President, R&D of UnitedHealth Group
Follow Ben Wiegand:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Sebastian Kronmueller
Vice President, Head of Strategy & Business Development – Laboratory Diagnostics of Siemens Healthineers
Sebastian Kronmueller incubates startup businesses within Healthineers with a focus on novel molecular applications. His current incubation businesses include the Siemens Healthcare Laboratory in Berkeley, California and NEO New Oncology in Cologne, Germany. Previously he led the execution of strategic initiatives as Head of Special Projects for Siemens Healthineers, playing an instrumental role in shaping the strategy of Siemens Healthineers in preparation for the IPO planned in 2018. Before this role he led a project management team for companion diagnostics and software development and was responsible for the carve-out and divestment of the Healthineers Microbiology business. He began his career as strategy consultant with Siemens Management Consulting. Sebastian holds a graduate degree in physics from Ludwig-Maximilians-University in Munich, Germany and a graduate certificate in Management Science and Engineering from Stanford University in Palo Alto, California.
Follow Sebastian Kronmueller:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Elizabeth Colonna
Vice President of Health Enterprise Partners
Elizabeth joined HEP in 2016, while completing her MBA at Columbia Business School. Prior to business school, Elizabeth was a Senior Consultant at FTI Consulting (NYSE: FCN). As a member of FTI’s Health Solutions practice, she provided data analytics, litigation support, and other consulting services for a variety of healthcare clients, including large commercial payers, retail pharmacy chains, and healthcare data management companies. During her time in business school, she was a hospital administration and operations intern at UCLA Health. Elizabeth serves as a board observer of Wildflower Health and AxiaMed. Elizabeth holds a BA with Distinction from the University of Virginia and received Dean’s Honors with Distinction from Columbia Business School.
Follow Elizabeth Colonna:
About Health Enterprise Partners: Health Enterprise Partners is a private equity firm that provides its services for healthcare services and information technology companies.
Pete Tedesco
Vice President & Managing Partner of Health Enterprise Partners
Prior to joining HEP, Pete was a Vice President at Olympus Partners, a middle-market private equity firm managing over $5 billion. At Olympus, he was responsible for evaluating and executing leveraged buyout and growth equity transactions and served on the board of directors for companies across a variety of industries. Pete previously worked at Chicago-based private equity firm Waud Capital Partners, where he focused primarily on investments in the healthcare services sector, and in the Corporate Business Development group at Becton Dickinson & Co. (NYSE: BDX). Pete began his career in the Mergers & Acquisitions and Diversified Industrials groups at UBS Investment Bank. Pete holds an A.B. from Princeton University and an MBA from the Kellogg School of Management at Northwestern University.
Follow Pete Tedesco:
About Health Enterprise Partners: Health Enterprise Partners is a private equity firm that provides its services for healthcare services and information technology companies.
Vinod Mitta
Vice President – Pharmaceuticals of Oscar Health
Vinod Mitta is the Vice President at Oscar Health.
Follow Vinod Mitta:
About Oscar Health: Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Marco Taglietti
Executive Vice President of Forest Laboratories
Dr. Taglietti is Executive Vice President, Drug Development and Research, and Chief Medical Officer of Forest Laboratories, Inc. He continues to be President of the Forest Research Institute. He previously served as Senior Vice President—Research and Development of the Company and President, Forest Research Institute, Inc. from December 2010 to December 2013. Prior thereto, Dr. Taglietti served as Vice President—Research and Development from December 2008 to December 2010. Dr. Taglietti joined Forest in August 2007 as Executive Vice President—Research and Development and Chief Medical Officer of Forest Research Institute, Inc. Prior to joining Forest, Dr. Taglietti was Senior Vice President and Head of Global Research and Development at Stiefel Laboratories for three years. Prior to that, Dr. Taglietti was at Schering-Plough Corporation for twelve years in positions of increasing responsibility including Vice President—Worldwide Clinical Research for Anti-Infectives, Oncology, CNS, Endocrinology and Dermatology. Dr. Taglietti received his medical degree and board certifications from the University of Pavia in Italy.
Follow Marco Taglietti:
About Forest Laboratories, SCYNEXIS: Forest Laboratories, Inc. (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships.
Rajesh Nair
President of Indegene Lifesystems
Dr Rajesh Nair is one of the cofounders of the company, and as the President, he is responsible for new strategic initiatives, especially as they relate to the company’s solutions in RWD-driven R&D for the life sciences. Prior to cofounding Indegene, Dr Nair headed the Biotech division of the Sarabhai Group. He is a physician by training, having earned the MBBS degree from GMC Trivandrum, India. He then pursued MBA from IIM Ahmedabad (1997), India.
Follow Rajesh Nair:
About Indegene, Indegene Lifesystems: Indegene helps global healthcare organizations address complex challenges by seamlessly integrating Analytics, Technology.
Sanjay Virmani
Executive Vice President of Indegene Lifesystems
Sanjay Virmani is the CEO at Exeevo Inc.
Follow Sanjay Virmani:
About Exeevo, Indegene Lifesystems: Indegene helps global healthcare organizations address complex challenges by seamlessly integrating Analytics, Technology.
Sameer Lal
Senior Vice President of Business Development of Indegene Lifesystems
Follow Sameer Lal:
About Indegene Lifesystems: Indegene helps global healthcare organizations address complex challenges by seamlessly integrating Analytics, Technology.
Florent Peyre
Co-Founder & President of Small Door
Follow Florent Peyre:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Anna Fagin
Vice President & Principal of Town Hall Ventures
Anna Fagin serves as the Vice President and Principal at Town Hall Ventures.
Follow Anna Fagin:
About Town Hall Ventures: Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology.
Hal Pyke
Vice President of PetVet Care Centers
Follow Hal Pyke:
About PetVet Care Centers, United States Taekwondo Association: PetVet Care Centers is an operator of specialty and general practice animal hospitals in the United States.
William Friedman
Vice President of Health Plan Partnerships of Carrot Fertility
Prior to joining Zipari, Bill held senior positions in the Health Payer space for many years. He was Senior Vice President and Chief Sales Officer for Health Republic Insurance of New York. At the largest CO-OP Health Insurance Carrier in the nation, Bill led sales operations, broker relations, strategic sales planning and marketing. He designed, developed and implemented the sales methodology leading to the company’s growth from Start-Up to a Billion dollar revenue stream. Prior to joining Health Republic Bill was Senior Vice President of Sales at Easy Choice Health Plan of New York where he was instrumental in the launch of the company’s Medicare Advantage products. Bill also spent 8 years at Atlantis Health Plan as SVP of Sales. Atlantis was a Commercial Provider owned HMO focused on the Individual and Group Market. Bill has a deep understanding of customer engagement and retention strategies in the health payer world and has intimate knowledge of the challenges faced by the industry in the post PPACA healthcare landscape.
Follow William Friedman:
About Carrot Fertility: Carrot Fertility helps employers offer their workers fertility benefits that are flexible, transparent, and cost-conscious.
Tim Tompkins
Vice President & Deputy Chief Information Security Officer of CVSHealth
Vice President & Deputy Chief Information Security Officer at CVS Health.
Follow Tim Tompkins:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Dennis Kaltman
President of Multi Packaging Solutions
Dennis Kaltman was given responsibility for the global Branded Consumer market in February 2014, following the merger with Chesapeake. In this role, Dennis focuses on providing the best total value to MPS customers and maintaining a competitive edge through technical innovation and personnel development. He joined MPS in August 2005 as Executive Vice President and Chief Operating Officer. He was named President in August 2007. Dennis brings more than 20 years of experience in the print and packaging industry. He started his career with Queens Group, where he was Senior Vice President from 1990 to 1998. When Queens Group was acquired by Shorewood Packaging in 1998, Dennis was named Senior Vice President. In that role, he became intimately involved in the acquisition and integration of numerous specialty packaging businesses. Following the acquisition of Shorewood by International Paper in 2000, Dennis served as Senior Vice President of the Home Entertainment Packaging Division until he joined MPS.
Follow Dennis Kaltman:
About Multi Packaging Solutions: Multi Packaging Solutions provides packaging solutions for healthcare markets.
Joseph Davi
Co-founder/President & CEO of Med-Metrix
Joe has over 20 years of demonstrated success in healthcare executive leadership. Together with other senior management, Joe directs and executes Med-Metrix’s primary corporate initiatives and actively implements our strategic plans. Prior to becoming Med-Metrix’s CEO, Joe most recently served as the President of Cobblestone Capital Associates, a private equity firm he founded. He has been an investor and board member in several acquisitions and portfolio companies. Previously, Joe was the President and co-founder of MD-X Solutions (acquired by MedAssets), a revenue cycle company named by Deloitte among the 100 fastest growing technology companies in North America. He later served as the President of MedAssets’ revenue cycle services division. Joe’s career also includes positions at Lehman Brothers, Bankers’ Trust, and NPPN, a national Preferred Provider Organization (PPO). Joe holds a Bachelor’s degree in History from Princeton University and an M.B.A in Finance and Accounting from the University of Chicago Booth School of Business. Joe is a Fellow of the Healthcare Financial Management Association (FHFMA) and was named a Finalist by Ernst & Young for Entrepreneur of the Year in 2005.
Follow Joseph Davi:
About Med-Metrix: Med-Metrix provides Performance Management and Revenue Cycle solutions to the healthcare industry.
Ofer Leidner
Co-Founder & President of Happify Health
As Co-Founder and President of Happify Health, Ofer is an experienced entrepreneur who came into healthcare after spending a decade developing casual games and has a deep expertise in user engagement, gamification and digital delivery platform at scale. Alongside his Co-Founder, Tomer Ben-Kiki, Ofer is committed to developing evidence-based therapeutic interventions to treat, manage or improve people’s mental or physical health through meaningful behavior change. Offered to employers, health plans and pharmaceutical companies, Happify Health’s solutions incorporate behavior therapies, such positive psychology, cognitive behavioral therapy and mindfulness. The company’s clinically-validated digital therapeutic solutions will be FDA-cleared as prescription digital therapies (PDT). Prior to Happify Health, Ofer co-founded several digital media businesses, including iPlay/Oberon Media, a leading casual gaming company and customer relations software startup, Gate42 Technologies. Ofer holds an MBA in Finance and a B.A. in Economics and Information Technologies, both from Tel Aviv University.
Follow Ofer Leidner:
About Happify Health: Happify Health is a healthcare platform, combining digital therapeutics and care delivery solutions to improve mental and physical health.
Heberto Calves
President – Myx Fitness of Beachbody
Follow Heberto Calves:
About Beachbody: Beachbody has developed and offering an in-home fitness and weight loss solutions.
Vaibhav Narayan
Vice President, Digital Health Innovation of Johnson & Johnson
Follow Vaibhav Narayan:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ravi Parameswar
Vice President, Head of Global Strategic Insights & Analytics of Johnson & Johnson
Follow Ravi Parameswar:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Amy Foley
Vice President, Product Innovation & Delivery of Johnson & Johnson
As Vice President of Product Innovation & Delivery, Amy Foley leads the Johnson & Johnson portfolio of health and wellness capabilities, including new product and service innovation, creation, implementation, operations, customer service and compliance and quality.
Follow Amy Foley:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ismail Kola
Executive Vice President & President UCB NewMedicines of UCB
Dr. Kola has served as our Director since October 18, 2010. Dr. Kola currently serves as Executive Vice President of UCB S.A. in Belgium, a biopharmaceutical company dedicated to the development of innovative medicines focused on the fields of central nervous system and immunology disorders, and also serves as President of UCB New Medicines, UCB’s discovery research through proof-of-concept organization, since November 2009. Since March 2007, Dr. Kola was Senior Vice President, Discovery Research and Early Clinical Research & Experimental Medicine, and Chief Scientific Officer at Schering-Plough Corporation. Previously, Dr. Kola held senior positions commencing in 2003 at Merck & Company, where he was Senior Vice President and Site Head, Basic Research, and responsible for atherosclerosis and cardiovascular diseases, diabetes, obesity, infectious diseases, immunology and rheumatology, animal pharmacology and basic and medicinal chemistry. Prior to that, Dr. Kola was Vice President, Research, and Global Head, Genomics Science and Biotechnology, with Pharmacia Corporation, and served as consultant to SmithKline Beecham Pharmaceuticals, where he was also a member of the Genomics Advisory Board. During his tenure of proven leadership at several major pharmaceutical companies, Dr. Kola has overseen the successful development of numerous innovative new medicines, including products in the fields of diabetes, cancer, cardiovascular diseases and central nervous system disorders.
Follow Ismail Kola:
About UCB: UCB Pharma is a biopharmaceutical and specialty chemical company.
John DeYoung
Vice President of Worldwide Business Development of Pfizer
John DeYoung is Vice President of Worldwide Business Development for Pfizer Oncology. He is a member of the Oncology Leadership Team and the Worldwide Business Development Leadership Team. John joined Pfizer in 1991 and has held leadership positions in Finance, Marketing, Commercial Development and Business Development. He received a bachelor’s degree in business from Michigan State University and an M.B.A. from the University of Chicago.
Follow John DeYoung:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Morten Sogaard
Vice President and Head, Target Sciences of Pfizer
Follow Morten Sogaard:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Sonal Bhatia
Vice President, North America Medical Lead of Pfizer
Follow Sonal Bhatia:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Juliana Anderson
Vice President of Tailwind Capital
Juliana Anderson currently works as the Vice President for Tailwind Capital. She previously worked at CapitalSource Bank as the Senior Analyst.
Follow Juliana Anderson:
About Tailwind Capital: Tailwind focuses on growing middle market companies in the healthcare, business services, and media/communications sectors.
David Pontius
Vice President of WindRose Health Investors
Follow David Pontius:
About WindRose Health Investors: WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare.
Ilan Abehassera
Co-Founder, President & COO of Willo
Ilan Abehassera is the Co-Founder, President & COO at Willo.
Follow Ilan Abehassera:
About Diaspora Ventures, Oui Are New York, Willo: Willo develops technology in oral health that automatically empowers everyone to achieve the best at-home clean possible.
Serge Enokian
Senior Vice President of Sales & Marketing of Capsugel
Mr. Enokian is Capsugel’s Senior Vice President of Global Sales. He joined the Company in March 1986 and has served in a number of sales management and marketing positions with increasing responsibly, including Area Sales Manager, National Sales Manager, Director Marketing and the Director of Sales and Marketing for the Americas Region. Prior to joining Capsugel, Mr. Enokian worked for Eli Lilly’s Brazil affiliate, serving as Group Product Manager and National Sales Manager in their Agricultural Products Division. Mr. Enokian holds a bachelor’s degree in Economics and an M.B.A. from Louvain University in Belgium.
Follow Serge Enokian:
About Capsugel: Capsugel is a global leader in delivering high-quality, innovative dosage forms and solutions to healthcare companies around the world.
Humberto Antunes
President & CEO of Galderma
Humberto C. Antunes is a Partner at Gore Range Capital. Humberto has spent his career as an entrepreneur in healthcare and wellness focused on finding ways to improve the lives of people all over the world. His previous experience includes work in dermatology, ophthalmology, medical aesthetics, immunology, inflammation, cosmetics, medical devices, pharma and nutraceuticals. He is actively involved in research to address the issues arising from aging demographics, providing holistic health solutions, helping technologies converge and the digital revolution. Prior to joining Gore Range Capital, Humberto managed Galderma, a pharmaceutical company, for almost 20 years. From 2014 through 2016, he created and led Nestlé Skin Health, which endeavors to enhance quality of life by delivering science-based solutions for skin. Humberto promoted geographic expansion of the businesses he managed, created new channels and acquired new audiences. He also led many successful acquisitions, integrations, joint-ventures, license deals and divestitures. In addition, Humberto has led research teams that achieved hundreds of New Drug Applications, patent filings and clinical trials on both sides of the Atlantic. Some of his successful digital initiatives include www.derm101.com and www.acne.com.
Follow Humberto Antunes:
About Galderma, Gore Range Capital: Galderma offering a range of medical and consumer skin health solutions through three business units.
Josue Munoz
Vice President Global Customer Service, Logistics & Supply Chain Systems of Colgate Palmolive
Follow Josue Munoz:
About Colgate Palmolive: Colgate-Palmolive is a consumer products company that produces, distributes, and provides household, healthcare, and personal products.
Neal Meropol
Vice President, Head of Medical and Scientific Affairs of Flatiron Health
Neal J. Meropol is a medical oncologist, clinical investigator and health outcomes researcher who serves as vice president of research oncology at Flatiron Health. In this role, he leads efforts to leverage Flatiron’s technology platforms and nationwide provider network to gain insights from real-world data that accelerate research and improve quality of care for cancer patients. Prior to joining Flatiron, Neal was professor and chief of the division of hematology and oncology at University Hospitals Cleveland Medical Center and Case Western Reserve University, and associate director for clinical research at the Case Comprehensive Cancer Center. Neal has a national reputation for his research contributions in gastrointestinal malignancies and health services research, including evaluation of new agents, predictors of response and outcome, development of tools to overcome barriers to clinical trial participation, and assessment of the economic impact of care. He currently serves as chair emeritus of the National Cancer Institute Gastrointestinal Cancer Steering Committee, which oversees the development of clinical trials in the publicly-funded clinical trials system. Neal recently completed a four-year term as an elected member of the American Society of Clinical Oncology Board of Directors. He has authored more than 250 manuscripts, book chapters, and editorials related to cancer prevention, treatment, decision making, and health economics. Neal received his undergraduate degree in philosophy from Princeton University and MD from Vanderbilt University. He was a resident in internal medicine at Case Western Reserve University, and completed hematology and medical oncology fellowships at the University of Pennsylvania. He spent a sabbatical at the Leonard Davis Institute of Health Economics at the Wharton School of the University of Pennsylvania.
Follow Neal Meropol:
About Flatiron Health: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Marta Bralic
Senior Vice President of Business Development of Flatiron Health
Marta Bralic Kerns is the Founder & CEO at Pomelo Care. She attended Harvard University.
Follow Marta Bralic:
About Flatiron Health, Pomelo Care: Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.
Julie Zuckerman
Vice President of Clinical Operations & Physician Assistant of Schweiger Dermatology
Julie Zuckerman, RPA-C is a licensed Physician Assistant at Schweiger Dermatology. She is members of the American Academy of Physician Assistants, the Society of Dermatology Physician Assistants, the New York Society of Dermatology PA’s, and the American Association of Surgical Physician Assistants. She received her Physician Assistant degree, with a surgical specialization and focus in dermatology, from Weill Cornell Medical College. She graduated as a member of the Pi Alpha Honor Society. Julie then completed her Physician Assistant training at several Manhattan hospitals including the New York Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. She received her undergraduate degree from the University of Michigan with a B.A. in Psychology and a Pre-Medical focus.
Follow Julie Zuckerman:
About Schweiger Dermatology: Schweiger Dermatology is a full service cosmetic & general dermatology.
Robb Knie
CEO, President & Director of Hoth Therapeutics
Mr. Knie has served as President and Chief Executive Officer and as a director of the Company since May 2017. Mr. Knie served as the President of Lifeline Industries Inc. since its inception in 1995. From 2002 to 2010 he was a Semiconductor Analyst for PAW Partners. From 1993 until 1995, Mr. Knie served as Northeast Regional Manager of American Express Financial Advisors. Mr. Knie has served as a board member for NASDAQ-listed companies. He has been featured on CNBC, Bloomberg, The Wall Street Journal and Forbes Magazine as an Independent Equity Analyst. Mr. Knie has over 20 years of equity markets experience. Mr. Knie has been a member of the American Chemical Society, Institute of Electrical and Electronics Engineers, as well as The National Alliance for Youth Sports.
Follow Robb Knie:
About Hoth Therapeutics: Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders.
Yin Becker
Vice President, Chief Corporate Affairs Officer of Stryker
Follow Yin Becker:
About Stryker, Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Elizabeth A. Staub
Vice President, Regulatory Affairs and Quality Assurance of Stryker
Elizabeth A. Staub was named Vice President, Regulatory Affairs and Quality Assurance, in April 2006. Ms. Staub is responsible for overseeing Stryker’s compliance with worldwide product quality and regulatory requirements, including FDA and other regulatory bodies. Ms. Staub began her career with Stryker in April 1989 and held a number of quality, regulatory and operational positions within the Company’s Orthopaedics division, including Manager, Quality Assurance; Team Leader for the packaging cell; Manufacturing Team Leader for the external support cell; Director of the Knee Steering Team; Vice President, Quality Assurance, Regulatory Compliance and Clinical Research; and Director of the Business Process Excellence Project. She then served as Director, Regulatory Affairs and Quality Assurance, for the Company from 2005 to 2006. Prior to joining Stryker, Ms. Staub spent six years with Baxter Healthcare in a variety of quality assurance positions. Ms. Staub holds a B.S. in Medical Technology from York College of Pennsylvania.
Follow Elizabeth A. Staub:
About Stryker: Stryker is a medical technology company that offers products and services in orthopaedics.
Konstantin Mehl
CEO, Founder & President of Kaia Health
Konstantin is a serial entrepreneur. His last company foodora, a global food delivery company was sold to delivery hero in 2015 after reaching 500 employees and 5,000 drivers. His current company Kaia has the mission to build the biggest platform for chronic disease management, powered by computer vision. His angel investments include more than 20 companies in the US and Europe. He holds a dual Masters from Columbia University and a Bachelors degree from Technical University Munich.
Follow Konstantin Mehl:
About Kaia Health, Kaia Health: Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of medical disorders.
Dieter Weinand
President and CEO of Bayer Pharmaceuticals
Weinand currently serves as President of Bayer Pharmaceuticals and is a member of the Board of Management of Bayer AG. Previously, he was President, Global Commercialization & Portfolio Management at Otsuka. During his 30 year career, he has held various responsibilities in commercial, operations and strategy in various therapeutic areas including cardiovascular diseases, oncology, dermatology, immunology, and respiratory and inflammatory diseases . These positions included heading business operations in markets in the United States, Asia-Pacific, Europe, the Middle East, Africa, and Latin America for companies including Pfizer and Bristol-Myers Squibb. He earned an M.S. in pharmacology and toxicology from Long Island University, New York, and a B.A. in biology from Concordia College, New York.
Follow Dieter Weinand:
About Bayer Pharmaceuticals: Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Mattan Griffel
Co-Founder/President & COO of Ophelia
Mattan is an award-winning faculty member at Columbia Business School and a two-time Y Combinator-backed entrepreneur. He co-founded Ophelia, a company that helps people quit opioids without having to go to rehab. Mattan is also an Innovation Fellow at the Lang Center for Entrepreneurship and was selected as one of Forbes’ 30 Under 30 in Education.
Follow Mattan Griffel:
About One Month | Learn to Code in 30 Days, Ophelia, Sandbox Network: Ophelia offers medication and support for quitting opioids.
John Buser
President and Chief Executive Officer of Health Solutions Plus
Health Solutions Plus was founded in 1996, by John Buser, founder and former COO and CIO of Centercare, a New York health plan. Before founding HSP, Mr. Buser spent 30 years in technology, software and operations management and served in senior leadership. Prior to joining the healthcare industry, Mr. Buser was the senior technical manager for international consulting firm Logica LLC. During his tenure at Logica, Mr. Buser was responsible for developing banking and telecommunications systems for such clients as Citibank, Chase, JP Morgan, Chemical, MHT, Philadelphia Federal Reserve Bank, Bank of Boston and IBM.
Follow John Buser:
About Health Solutions Plus: Health Solutions Plus (HSP) is a U.S. based software provider of the most modern Payer administration solutions in the industry.
Julie Rubinstein
President of Adaptive Biotechnologies
Ms. Rubinstein is the president of Adaptive Biotechnologies Corp.
Follow Julie Rubinstein:
About Adaptive Biotechnologies, Adaptive Biotechnologies, Adaptive Biotechnologies: Adaptive Biotechnologies translates a scale and precision of the adaptive immune system into products to diagnose and treat disease.
Taylor Justice
Co-Founder & President of Unite Us
Follow Taylor Justice:
About Unite Us: Unite Us provides a collaboration and coordination software, streamlining the delivery of health and social services.
Darren Sherman
President, Chief Operating Officer, Director and Founder of Orchestra BioMed
Darren Sherman is a Managing Partner of Orchestra. He is also Chief Technical Officer of Accelerated Technologies, Inc. (ATI) as well as Chief Executive Officer of Caliber Therapeutics, Inc., an OMV II Fund Portfolio Company. He has over 17 years of management and entrepreneurial experience in the medical technology industry spanning interventional cardiology, cardiac electrophysiology, sudden cardiac death, stroke, and neurovascular therapies. He currently serves as a director of Caliber Therapeutics and Vivasure Medical. Prior to joining Orchestra, Mr. Sherman held various positions in executive management for Cordis Neurovascular (CNV), a Johnson & Johnson company, including Executive Director R&D and Director of Strategic Marketing for stroke products. He had worldwide responsibility for all neurovascular R&D and global strategic marketing responsibilities for the Stroke franchise, including budgets, portfolio of products and strategic planning. Mr. Sherman made significant contributions to the design and commercialization of a series of key products including the Enterprise Vascular Reconstruction Device and the Orbit Embolic Coil as well as directed the filing of over 100 patents. Prior to joining CNV, Mr. Sherman played an integral role in the formation and development of Revivant Corp (acquired by Zoll) while working with Thomas J. Fogarty, MD at Fogarty Engineering. He was Revivant’s first employee and managed the design, development, and testing of the AutoPulse device from concept through market introduction. In addition to the R&D related activities, Mr. Sherman supported the clinical research, marketing, and intellectual property efforts. The AutoPulse is a lightweight, portable tool replacing the need for manual chest compressions during cardio-pulmonary resuscitation (CPR) for patients suffering from sudden cardiac arrest. Prior to Revivant, Mr. Sherman held positions in research and development for Cardiac Pathways Corp., prior to its acquisition by Boston Scientific, and Baxter Healthcare. In each of these companies, he participated in the creation, development and launch of products. Mr. Sherman has authored 45 U.S. patents with an additional 58 published applications. He earned a BS degree in Bioengineering from the University of California, San Diego.
Follow Darren Sherman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Susan Sender
Chief Clinical Officer and Senior Vice President of Kindred Healthcare
Susan Sender, RN, BSN, CHCE, is Chief Clinical Officer and Senior Vice President of Clinical Services for Kindred at Home. Ms. Sender joined the company in July 2013 bringing to Kindred nearly three decades of experience. She spent the last five years with Loving Care Agency, a regional provider of home health services in New Jersey, as Chief Clinical Officer and Vice President of Pediatric Operations where she directed increased diversity in payer sources and drove standardization in clinical and business process through quality improvement and policy development. Prior to that, Ms. Sender was Vice President and Chief Nursing Executive with Gentiva, the largest U.S. provider of comprehensive home health services, a position she held for nearly a decade. She also worked for Olsten Health Services, a home healthcare company based in Westbury, NY, where she served as the Corporate Director of Clinical Practice. Ms. Sender has a BSN from Adelphi University in Garden City, NY, and has published articles on a variety of topics, including home care policy, pain management, reducing rehospitalizations, outcomes tracking, and compliance.
Follow Susan Sender:
About Kindred Healthcare: Kindred Healthcare is a provider of care in settings from hospitals to even your own home.
Christopher Seaton
Senior Vice President, Negotiations of Bayer HealthCare
Chris is responsible for major transactions in Bayer HealthCare, including licensing, product acquisition, divestitures and out-licensing. Mr. Seaton is based in the United States with direct reports in the USA and Germany. Mr. Seaton earned both his Masters of Business Administration and his undergraduate degree from McMaster University, Hamilton, Ontario, Canada. Mr. Seaton has had experience in multiple countries and businesses. Immediately prior to his current role he was responsible for Business Development and Licensing for Bayer HealthCare (a predecessor of Bayer Schering Pharmaceuticals AG) and prior to that, for Business Planning and Administration for Bayer HealthCare in North America, a function which covered Finance, Information Systems, Strategic Planning and North American Licensing.
Follow Christopher Seaton:
About Bayer HealthCare: Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
Roxanne Lagano
Executive Vice President and Chief Human Resources Officer of Zoetis India Ltd
Roxanne Lagano was appointed executive vice president and chief human resources officer at Zoetis in November 2012. In this role, she is responsible for the company’s worldwide human resources management. Prior to joining Zoetis, Ms. Lagano was senior vice president, Global Compensation, Benefits and Wellness for Pfizer. In that role, Ms. Lagano was responsible for the design and implementation of Pfizer’s compensation and employee benefit programs around the globe. She was also responsible for Pfizer’s wellness strategies, including the Healthy Pfizer program, and for the human resources aspects of the company’s merger, acquisition and divestiture activities. Ms. Lagano joined Pfizer in 1997 as manager, Tax Planning after specializing in employee benefits, executive compensation and mergers and acquisitions at Schulte, Roth and Zabel, LLP, a New York law firm. After joining Pfizer’s legal division in 1999, Ms. Lagano joined Pfizer’s Human Resources organization in 2000. During her time in HR for Pfizer, Ms. Lagano held various positions of increasing responsibility, including senior director of business transactions (HR) and senior director, employee benefits. Ms. Lagano holds a Juris Doctor degree from Hofstra University School of Law and a Bachelor of Science degree from Long Island University.
Follow Roxanne Lagano:
About Zoetis India Ltd: Zoetis provides healthcare services for animal.
Paul Herendeen
Executive Vice President and Chief Financial Officer of Zoetis India Ltd
Paul Herendeen is executive vice president and chief financial officer (EVP and CFO) of Zoetis. In his role, Herendeen oversees the company’s Finance and Information Technology organizations and serves as part of the Zoetis Executive Team, reporting to CEO Juan Ramón Alaix. Herendeen brings more than 30 years of broad financial experience and leadership to his role at Zoetis, including 16 years as CFO of Warner Chilcott and MedPointe. From 2005 to 2013, Herendeen served as CFO at Warner Chilcott, a specialty pharmaceuticals company, which had a successful IPO in 2006, grew its revenue and profitability, and was acquired by Actavis in 2013. He joined Warner Chilcott after four years as EVP and CFO of MedPointe, a privately held health care company. He had been Warner Chilcott’s CFO from 1998 until 2000, joining the company after representing one of its lead investors on Warner Chilcott’s Board of Directors. Herendeen helped grow the company’s revenues and conduct its first successful IPO, and later helped complete the company’s acquisition by Galen PLC. From 1989 to 1998, Herendeen spent nine years as a principal investor at both Dominion Income Management and Cornerstone Partners, where he worked on investments as well as mergers and acquisitions for the firms and their portfolio companies. He also spent the early part of his career in banking and public accounting, having held various positions with the investment banking group of Oppenheimer & Company, the capital markets group of Continental Bank Corporation, and as a senior auditor with Arthur Andersen & Company. Herendeen earned a Master of Business Administration (MBA) from the University of Virginia’s Darden School of Business, and holds a bachelor’s degree in Business Administration from Boston College.
Follow Paul Herendeen:
About Bausch Health, Zoetis India Ltd: Zoetis provides healthcare services for animal.
Mia Funt
President and CEO of ByHeart
Mia (Belldegrun) Funt is the Co-founder and President of ByHeart.
Follow Mia Funt:
About ByHeart: ByHeart is an infant nutrition company that translates nutrition science and breastmilk research into evolved foods and formulas.
Alex Moczarski
President & CEO of Guy Carpenter & Company
Alexander Moczarski is President and Chief Executive Officer of Guy Carpenter & Company, LLC and Chairman of Marsh & McLennan Companies International. Mr. Moczarski is Chairman of Guy Carpenter’s Board of Managers and is a member of the Marsh & McLennan Companies Executive Committee. Prior to joining Guy Carpenter in 2011, Mr.Moczarski served as President and CEO of Marsh’s International Division. Previously, he was CEO of Marsh Inc.’s Europe, Middle East and Africa region. While at Marsh, he held several other roles, including President and CEO of the firm’s International Specialty Operations and Region Head for the Latin America and Caribbean Region. Before joining Marsh in 1993, Mr. Moczarski worked for AIG for nearly 15 years, most recently as CEO of the firm’s operations in Argentina and Chile.
Follow Alex Moczarski:
About Guy Carpenter & Company: Guy Carpenter & Company, LLC operates as a reinsurance intermediary. The company offers accident and health, agriculture, alternative risk
Thomas Brown
CIO and Executive Vice President, Enterprise Services and Operations of Nuance Communications
Thomas “T” Brown is the senior vice president of Services and Operations within Nuance’s Enterprise Division, supporting customer self-service solutions that are used by leading organizations around the world to automate and optimize the customer care experience across all channels including phone, web, and mobile. In this role, Mr. Brown is responsible for leading the divisions’ global services organization, including the day-to-day operations and global strategy for Enterprise Professional Services, Network Services, Global Hosting and Infrastructure, and On-Demand teams and businesses. Prior to joining Nuance, Mr. Brown spent more than a decade in senior technical and management positions with Hughes Aircraft Company, Hewlett Packard, and Bell Laboratories. Mr. Brown holds a BS degree in Computer Science from Penn State University and a MS degree in Computer Science from UCLA.
Follow Thomas Brown:
About : Nuance Communications provides conversational AI innovations that bring intelligence to everyday work and life.
Richard Kresch
President and CEO of Ascend Health
Follow Richard Kresch:
About Ascend Health, US HealthVest: Ascend Health Corporation is a leading behavioural healthcare provider, offering a full range of inpatient and day hospital services.
Alan Rigby
Co-Founder, President & Chief Executive Officer of HiberCell
Alan Rigby is a passionate and innovative oncology leader with over 20 years of academic and industry experience in the area of data driven oncology drug discovery from concept to clinical candidate to genetically enabled first-in-man studies. Dr. Rigby is committed to leveraging patient material and data for use in the identification, stratification and development of ‘next generation’ cancer therapeutics for use in responder populations. This ‘commitment’ has resulted in clinically validated large and small molecule therapeutics for several cancer indications. Most recently, Alan led a prioritized and focused effort to translate ‘Natures Intracellular Biologic’ into transformative medicines for oncology and antibiotic resistance while chief scientific officer of Warp Drive Bio., a Cambridge based biotechnology company that was recently acquired. Alan joined Warp Drive Bio following a tenure as senior vice president and chief scientific officer at Synta Pharmaceuticals. While at Synta Alan led research and development efforts for Synta’s HSP90 clinical candidate, Ganetespib, as well as restructuring the preclinical small molecule drug conjugate platform. Prior to joining Synta, Dr. Rigby was vice president, global antibody drug conjugate biology, and head of external innovation for oncology research at the New York site for Eli Lilly and Company. Before launching his biotech/ pharmaceutical career Dr. Rigby was a National Institutes of Health (NIH) funded assistant professor and principal investigator at Beth Israel Deaconess Medical Center, Harvard Medical School. While at Harvard Medical School, he founded and directed the Drug Discovery and Target Validation Program within the Beth Israel Deaconess Medical Center. As a mentor and advisor Alan continues to work with numerous organizations to assemble and chair scientific conferences with a focus on translating innovative science and oncology-centric platforms into robust and durable clinically validated strategies. Alan Rigby is on the Editorial Advisory Board for Future Medicinal Chemistry, was North American Editor for Current Computer Aided Drug Discovery and has published more than 55 scientific papers, a book chapter and has 12 patents that have published or are pending. Alan holds an Honors BSc. in Biochemistry from the University of Western Ontario in London, Ontario, Canada and a Ph.D. in Biochemistry from the same University.
Follow Alan Rigby:
About HiberCell: HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Jack Lefkowitz
CEO and President of Care to Care LLC
Follow Jack Lefkowitz:
About Care to Care LLC: Care To Care provides specialty benefits and utilization management services to managed care organizations and other healthcare payers.
Jay Anderson
Senior Vice President of Global Brand Technologies of Estee Lauder Companies
Jay Anderson is the Senior Vice President, Global Brand Technologies at The Estée Lauder Companies, one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in 150 countries and territories under brand names including Estee Lauder, MAC, Clinique, Tom Ford, La Mer, Aveda, Jo Malone London and Too Faced. Jay drives brand growth by overseeing the creation of innovative technology solutions that enhance luxury consumer experiences, engagement and personalization. He also leads the IT strategic vision, portfolio execution, and corporate technology innovation. Previously, Jay served as the company’s interim CIO, global head of applications and analytics, and head of value chain technology and tech innovation. Jay grew up in Milwaukee, Wisconsin and graduated Cum Laude from Harvard College. He also received a joint MBA and Industrial Engineering degree from the University of Michigan.
Follow Jay Anderson:
About Estee Lauder Companies: Estee Lauder Companies is a manufacturer and marketer of skincare products, makeup, perfumes, and hair care products.
Karen Totland
Vice President, Global Procurement, Global Facilities & Corporate Sustainability of FMC Corporation
Karen M. Totland, Ph.D. serves as Vice President, Global Procurement, Global Procurement and Corp Sustainability for FMC Corporation Karen joined FMC in November of 2010, from Firmenich, a leading Fragrance and Flavor company based in Switzerland where she spent 14 years, most recently as Vice President, Global Purchasing. Here she obtained experience leading purchasing and strategic sourcing at a global level. Karen has a proven track record building new organizations, achieving bottom-line results and developing talent. A trained chemist, Karen has a Ph.D. from the University of Ottawa and has conducted post-doctoral research at the Massachusetts Institute of Technology. During the course of her career Karen has lived in Europe, the Middle East and North America. She grew up in Canada and has Canadian and French citizenship. Karen currently resides in Philadelphia PA.
Follow Karen Totland:
About FMC Corporation: FMC Corporation is an US-based chemical manufacturing company producing solutions for the agricultural, textile, and healthcare industries.
Robert Glenning
President Financial and Information Technology Services and CFO of Hackensack Meridian Health
Follow Robert Glenning:
About Hackensack Meridian Health: Hackensack Meridian Health is poised to better meet the needs of their communities.
Joseph Lemaire
President of Hackensack Meridian Health
Follow Joseph Lemaire:
About Hackensack Meridian Health: Hackensack Meridian Health is poised to better meet the needs of their communities.
Nathaniel McNamara
President & Founder of Studio
Nathaniel focuses on investments in information technology and is involved in all stages of the investment process.
Follow Nathaniel McNamara:
About FounderDating, Studio: Studio makes audio based group running classes available live and on-demand to anyone with access to a treadmill.
John Weiland
Vice Chairman, President and Chief Operating Officer of C. R. Bard
John H. Weiland joined C. R. Bard, Inc. on March 1, 1996. His experience spans over 30 years in the healthcare industry with firms such as Dentsply International, Pharmacia and Baxter Healthcare Corporation. John was elected to the Board of Directors in April 2005 and assumed the title of Vice Chairman in August 2016.
Follow John Weiland:
About C. R. Bard: C. R. Bard is a developer, manufacturer, and marketer of medical technologies.
Patricia Christian
Vice President, Regulatory Affairs of C. R. Bard
Patricia G. Christian joined C. R. Bard, Inc. in December 2008 as Vice President, Regulatory Affairs. She became Vice President, Quality Assurance in February 2011 and was promoted to Vice President, Quality, Regulatory and Medical Affairs in January 2014. She returned to the role of Vice President, Regulatory Affairs in July, 2016. Patty came to Bard from Johnson & Johnson, which she joined in 1997 as Manager, Regulatory Affairs before a promotion to Director, Regulatory Affairs for Independence Technology in 1999. In 2001, she became Director, Regulatory and Clinical Affairs for Vistakon, a division of Johnson & Johnson Vision Care, and was promoted to Senior Director in 2003. Most recently, Patty served as Vice President, Worldwide Regulatory Affairs for LifeScan, Inc.
Follow Patricia Christian:
About C. R. Bard: C. R. Bard is a developer, manufacturer, and marketer of medical technologies.
Todd Garner
Vice President – Investor Relations of C. R. Bard
Follow Todd Garner:
About C. R. Bard: C. R. Bard is a developer, manufacturer, and marketer of medical technologies.
Freya Zaheer
President of Sakara Life
Follow Freya Zaheer:
About Sakara Life: Sakara Life is an organic meal delivery and healthy living company that helps clients achieve health and well-being.
Nicola Kayel
Vice President & GI Marketing of Salix Pharmaceuticals
Nicola Kayel is a Vice President & GI Marketing at Salix Pharmaceuticals.
Follow Nicola Kayel:
About Salix Pharmaceuticals: Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Derek Chalmers
Co-founder, Chief Executive Officer, President & Director of Cara Therapeutics
Dr. Chalmers, one of our founders, has served as our President and Chief Executive Officer since September 2004 and has served as a member of our board of directors since July 2004. Dr. Chalmers has over 19 years experience in the biotechnology industry with increasing levels of corporate and business responsibilities. Prior to founding our company, Dr. Chalmers co-founded Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), a drug discovery and development company, and served as its Vice President and Executive Director from June 1997 until May 2004. Dr. Chalmers holds a B.Sc. and Ph.D. in Pharmacology from the University of Glasgow. Dr. Chalmers’ qualifications to sit on our board of directors include his leadership, executive, managerial and business experience, historical knowledge of our company and his background and experience in the biotechnology industry, including having been a founder of a prior biotechnology company.
Follow Derek Chalmers:
About Cara Therapeutics: Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.
Da Wi Shin
Co-Founder & President of Veripad
As Co-founder and Chief Operating Officer, Da Wi Shin manages internal operations, financial matters, and legal concerns. Da Wi personally became invested in the problem of counterfeit medication on his medical mission trip to Peru. When patients questioned the quality and effectiveness of antibiotics his team was providing for free, Da Wi felt the reality of the situation and the dire need for a working solution. Da Wi graduated from the Macaulay Honors College at the City College of New York (CUNY) with a degree in Biomedical Engineering. He hopes to be at the forefront of affordable medical technology for patients in developing countries.
Follow Da Wi Shin:
About Veripad: Veripad is a health IT company with a portable and affordable device to authenticate medication.
Joy Schare
Vice President of Operations of MediGain
Joy Schare is a VP of Operations for MediGain. As a registered nurse, Joy has a unique insight into the healthcare field; from the standpoint of both patient care and practice management. Joy has held several leadership nursing positions combining both clinical and business expertise. As the Regional Executive Director/Director of Clinical Operations for a major management company, Joy was instrumental in the development and expansion of their primary care and multi-specialty network. Additionally, Joy was instrumental in developing a successful billing and consulting firm providing services to medical providers throughout the Northeast. Joy holds a Master’s Degree in Public Administration from Long Island University.
Follow Joy Schare:
About MediGain: MediGain helps physicians by providing improved back-office processes and enabling more time and resources for patient care.
Marjolein Westerbeek
President USA of Rituals
Follow Marjolein Westerbeek:
About Rituals: Rituals is the first brand in the world to combine Home & Body cosmetics.
Nana Banerjee
Group President of Verisk
Dr. Nana Banerjee is group president of Verisk Analytics, overseeing Verisk’s Argus, Geomni, and Verisk Retail businesses. He also has oversight responsibility for Verisk’s joint data and development environment and Verisk’s centralized advanced research and analytics group. Dr. Banerjee came to Verisk as part of its acquisition of Argus, where he was the chief operating officer. In prior roles, he served as the head of Citibank’s credit card business in the United Kingdom and as vice president of marketing at GE Capital. Dr. Banerjee was named Verisk group president in 2016. Dr. Banerjee has a Ph.D. in applied mathematics from the State University of New York; a master of science degree in mathematics from the Indian Institute of Technology, Delhi; and a bachelor of science degree with honors in mathematics from St. Stephens College, Delhi.
Follow Nana Banerjee:
About Verisk: Verisk Analytics enables risk-bearing businesses for better understand and manage their risks.
Scott Stephenson
President and Chief Executive Officer of Verisk
Scott Stephenson is chairman, president, and chief executive officer of Verisk Analytics. During his tenure as CEO, Verisk was added to the S&P 500 Index and was named the eighteenth most innovative company in the world by Forbes magazine. In 2015, Institutional Investor named Scott Stephenson the number one CEO among sell-side analysts in Verisk’s industry category. He became chief operating officer of Verisk in 2008 and president in 2011. Before joining Verisk, Scott Stephenson was a senior partner with The Boston Consulting Group, a global management consulting firm. He also served as an advisor to Silver Lake Partners, a technology-oriented private equity firm. Earlier in his career, Scott Stephensonn designed components for missile propulsion systems. Scott Stephenson is a graduate of the University of Virginia, where he received a bachelor of science degree in mechanical engineering, and the Harvard Business School, where he received a master of business administration degree. Scott Stephenson has served on several civic and charitable boards, including the Data Science Institute at The University of Virginia, where he and his wife established The Stephenson Chair in Data Analytics. He is an elder of Central Presbyterian Church in New York City. Scott Stephenson is a graduate of the University of Virginia, where he received a bachelor of science degree in mechanical engineering, and the Harvard Business School, where he received a master of business administration degree. Scott Stephenson has served on numerous civic and charitable boards.
Follow Scott Stephenson:
About Verisk: Verisk Analytics enables risk-bearing businesses for better understand and manage their risks.
Ali Esmail
President of PopRx Inc.
Dr. Ali Esmail’s holds a wide range of skills and experiences: Otolaryngology,Head and Neck medical resident, while simultaneously maintaining expertise in innovation and software design in medical technologies. Dr. Esmail is a visionary and resourceful professional who received his MD from the University of Manitoba. From there, he was accepted into the highly competitive Otolaryngology/Head and Neck residency at the University of Manitoba, fulfilling a lifelong dream. During his residency he took an academic leave to complete a Masters of Business Entrepreneurship and Technology at the University of Waterloo in the department of engineering. He has Co-founded Koronis Inc. and PopRx.
Follow Ali Esmail:
About PopRx Inc.: A better pharmacy experience offered via web, mobile and digital technologies to empower healthcare and patient health outcomes.
Sudeep Pisipaty
Vice President of Strategy – Value Based Care of Health Recovery Solutions
Follow Sudeep Pisipaty:
About Health Recovery Solutions: Health Recovery Solutions develops a cloud-based warning system to help users reduce readmissions for hospitals and ACOs.
Eddie Bernard
Vice President for Research of Survival Capsule LLC
Dr. Eddie Bernard is a subject matter expert and consultant on issues dealing with tsunami warning systems, tsunami mitigation and education programs, and tsunami research. Dr. Bernard is currently an Affiliate Professor at the University of Washington and Scientist Emeritus for the National Oceanic and Atmospheric Administration’s (NOAA) Pacific Marine Environmental Laboratory (PMEL). He retired from Director of PMEL in 2010, after 40 years of NOAA service. In recognition of his outstanding service, he received three Presidential Rank Awards from Presidents Clinton, Bush, and Obama. As a noted oceanographer and expert on tsunamis, Dr. Bernard has published over 85 scientific papers and served as editor for three tsunami books. He has also produced a scientific movie on tsunami research and has been featured in over 20 television specials on tsunamis, including programs on The History Channel, The Learning Channel, National Geographic, and interviews on national television news programs.
Follow Eddie Bernard:
About Survival Capsule LLC, University of Washington: Survival Capsule is an intellectual property company that develops survival solutions for natural disasters.
Scott Hill
Vice President of Survival Capsule LLC
Scott began his career with a degree in Mechanical Engineering from Washington State University followed by work in aerospace with the Boeing Company (Everett, WA). more >> From his work on the 747, 757, 767, and 777 Boeing aircraft models, he has earned significant expertise and experience in design and stress analysis. Scott has also worked as a high-pressure design engineer for environmental control systems and has become highly proficient with installation/assembly/detail product structure development, 3D modeling programs, drafting, and Aerospace design requirements.
Follow Scott Hill:
About Survival Capsule LLC: Survival Capsule is an intellectual property company that develops survival solutions for natural disasters.
Susan Rappaport
Vice President, Research and Health Education of American Lung Association
Susan Rappaport is Vice President, Research and Health Education at American Lung Association.
Follow Susan Rappaport:
About American Lung Association: American Lung Association aims to save lives by improving lung health through research, education, and advocacy.
Joseph DePinto
President, Cardinal Health Specialty Solutions of Cardinal Health
Joe DePinto is president of Cardinal Health Specialty Solutions, a specialty healthcare business that helps healthcare providers and pharmaceutical companies optimize business functions and implement new innovations that move their businesses forward. Specialty Solutions is one of the fastest growing businesses of Cardinal Health. DePinto joined Cardinal Health from Sunesis Corporation, a hematology biotechnology company, where he served as executive vice president and chief commercial officer, and was responsible for global commercial build out, corporate communications, market and brand development and overall strategic and operational management of the organization. Prior to Sunesis, he served as executive vice president of Dendreon Corporation, where he was responsible for all aspects of global commercial operations. He has also held senior-level roles in operations, sales and marketing at Imclone Systems Incorporated, Abraxis Bioscience, Johnson & Johnson Pharmaceutical Services, Inc. and Ortho Biotech Products. DePinto holds a master in business administration degree in pharmaceutical chemical studies from Fairleigh Dickinson University and a bachelor of science degree in marketing.
Follow Joseph DePinto:
About Cardinal Health, Vineti: Cardinal Health is a company that improves the cost-effectiveness of health care.
Clare Carmichael
Senior Vice President, Chief Human Resources Officer of Enobia Pharma
Clare Carmichael is Senior Vice President, Chief Human Resources Officer, reporting directly to Leonard Bell, M.D., CEO. Clare is responsible for Human Resources on a global basis, with the goal of continuing to build a cohesive organization with integrated, high performance teams. Clare, who joined Alexion in August 2011, brings 30 years of HR experience with global pharmaceutical and biotech organizations to the organization. Prior to joining Alexion, she was SVP, Global Human Resources at Watson Pharmaceuticals, where she established and executed a strategy to successfully transition the workforce from a siloed U.S.-centric operation to a globally-focused matrix organization. Prior to Watson, Clare held several HR positions at Schering-Plough, including Vice President of Global Human Resources at the Schering-Plough Research Institute, where she was selected for the global HR lead role for R&D to help drive cultural change in the organization. While at Schering-Plough, she also spearheaded integration activities when the company acquired Organon Biosciences. Before Schering-Plough, Clare was the Vice President of HR at Eyetech Pharmaceuticals, leading the human resources function in the company from its post-IPO phase into the commercial phases of development. Prior to Eyetech, Clare was in Human Resources at Pharmacia.
Follow Clare Carmichael:
About Alexion Pharmaceuticals, Editas Medicine, Enobia Pharma: Enobia Pharma develops therapies for the treatment of serious genetic bone disorders.
Alvin Luk
Senior Vice President and Chief Medical Officer of Shanghai Henlius Biotech
Alvin Luk, Senior Vice President and Chief Medical Officer at Shanghai Henlius Biotech Inc., holds an MBA from Harvard Business School, earned his doctoral degree in Neuroscience from the University of California San Francisco Medical School (UCSF) and is certified for clinical research from the Association of Clinical Research Professionals. Previously,Dr. Luk has held executive positions at companies such as Spark, Biogen, BayerAG, Avigen (Sanofi) and Tularik (Amgen). He has over 26 years of global drug development, strategic management and clinical medical leadership experience. During 2006-2009, Dr. Luk was a member of the USA FDA Clinical Design Committee focusing on adaptive clinical trial designs to shorten drug development timeline. His early researches were focusing on gene regulation and expression, particularly emphasis on rare diseases, oncological diseases,biologics and regenerative medicines. Under his leadership in the development strategy for inherited retinal, neurodegenerative and hemophilia diseases, Dr.Luk has recently received the first US FDA AAV-gene therapy marketing approval and has won regulatory marketing approvals of 15 products as of today. Dr. Luk has published more than 50 scientific and medical articles in highly regarded peer-reviewed journals and book chapters and is an inventor on 8 patent applications.
Follow Alvin Luk:
About Shanghai Henlius Biotech: Shanghai Henlius Biotech is joint venture company that provides clinical-stage biopharmaceutical services.
Mario Reis
Executive Vice President, Supply Chain of Coty
Mario Reis is Coty’s Executive Vice President of Supply Chain and a member of Coty’s Executive Committee. Running our fully integrated, end-to-end Supply Chain, Mr. Reis plays a key role in facilitating the acceleration of profitable growth, faster speed to market of innovation as well as driving cost leadership at Coty. Over the last 30 years, Mr. Reis has built a solid experience in Fast Moving Consumer Goods (FMCG) Supply Chain with Mars Inc. and Danone, in Europe, Brazil and South Africa. Prior to joining Coty, Mr. Reis spent 16 years with Danone, where he held several senior executive positions in Global Operations. For the last 5 years, Mr. Reis served as Managing Director of Danone South Africa, growing the business vigorously and transforming it from a joint venture into a stand-alone company. Mr. Reis brings a holistic experience, covering both bottom line improvement and top line development. Building on analytical discipline gained early in his career as a consultant at Bain & Company, Mr. Reis’ key experiences include: setting up a continuous improvement program yielding annual delivered COGS gains; management of a global purchasing organization covering direct and indirect spend; design and implementation of product supply strategies including manufacturing and logistics; developing top line through consumer needs understanding and superior POS execution; management and development of global Supply Chain talent pool, based on skills, fostering local initiative and global experience sharing. A native of Mozambique, Mr. Reis holds a Bachelor of Science degree in Mechanical Engineering from Manchester University in the U.K. and an MBA from INSEAD.
Follow Mario Reis:
About Coty: Coty Inc is a New York based beauty company with portfolios in fragrance, color cosmetics and skin care.
Michael DiMaio
President of Empowered Education
Michael DiMaio is a Co-Founder and President at Empowered Education.
Follow Michael DiMaio:
About Empowered Education: Empowered Education is an education platform that trains coaches and practitioners in a new healthcare paradigm.
Ron Cohen
Founder, President and CEO of Acorda Therapeutics
Ron Cohen, M.D., President and Chief Executive Officer, founded Acorda Therapeutics, Inc. in 1995. Previously he was a principal in the startup and an officer of Advanced Tissue Sciences, Inc., a biotechnology company engaged in the growth of human organ tissues for transplantation. Dr. Cohen received his B.A. with honors in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons. He completed his residency in Internal Medicine at the University of Virginia Medical Center, and is Board Certified in Internal Medicine. Dr. Cohen is a member of the Executive Committee and Vice Chair of the Health Section of the Biotechnology Industry Organization (BIO), and serves on the Board of Directors of Dyax Corp. He previously served as Director and Chairman of the New York Biotechnology Association (NYBA). He also serves as a member the Columbia-Presbyterian Health Sciences Advisory Council and was awarded Columbia University’s Alumni Medal for Distinguished Service. Dr. Cohen was named NeuroInvestment’s (now called NeuroPerspective) CEO of the Year and was recognized by PharmaVoice Magazine as one of the 100 Most Inspirational People in the Biopharmaceutical Industry. He is a recipient of the Ernst & Young Entrepreneur of the Year Award for the New York Metropolitan Region and is an inductee of the National Spinal Cord Injury Association’s “Spinal Cord Injury Hall of Fame.” In 2010, Dr. Cohen was recognized by the New York Biotechnology Association as the NYBA “The Cure Starts Here” Business Leader of the Year.
Follow Ron Cohen:
About Acorda Therapeutics: Acorda Therapeutics began in 1995 as a network of scientists, physicians and business people with a common belief.
Christopher U. Missling
President & CEO of Anavex
Dr. Missling, the Chief Executive Officer (CEO) of Anavex, has over 20 years of healthcare industry experience within large pharmaceutical companies, the biotech industry and investment banking. He has been an investment banker in the healthcare practice at Deutsche Bank, serving pharmaceutical, biotech, and diagnostic companies, and most recently was head of healthcare investment banking at Brimberg & Co. in New York. At Aventis (now Sanofi), Dr. Missling worked as head of financial planning on all aspects of financial strategy and M&A. He was the Chief Financial Officer of Curis (NASDAQ: CRIS) and ImmunoGen (NASDAQ: IMGN) where during his tenure shareholder value increased significantly. Dr. Missling has an MS and PhD from the University of Munich in Chemistry and an MBA from Northwestern University Kellogg School of Management.
Follow Christopher U. Missling:
About Anavex: Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Eric Major
Chairman, CEO & President (Co-Founder) of K2M
Eric Major has served as President, Chief Executive Officer, and a member of our Board of Directors since January 2004, and is a co-founder of the Company. Mr. Major previously co-founded and served as the President and Chief Executive Officer of American OsteoMedix Corp., or AOM, a minimally invasive spinal device company that was acquired by Interpore Cross International in 2001. Following the sale of AOM, Mr. Major served as President of the Minimally Invasive Division for Interpore Cross International (now a Biomet company) until 2002. Prior to co-founding AOM, Mr. Major served in several sales/marketing, strategic and product development capacities with various spinal companies including Acromed Spine Inc. (now a Johnson & Johnson company) and Synthes Spine, Inc. Mr. Major has over 20 years of experience in the spine industry and was the 2010 recipient of the Entrepreneur of the Year Award for Emerging Technologies in the Greater Washington, D.C. region. Mr. Major is a member of the AdvaMed CEO Advisory Council and is active in the local community, serving on the Loudon Small Business Development Center Board of Directors, as well as the Board of Trustees for the Westmoreland Davis Memorial Foundation, Inc., a local historic preservation organization. Mr. Major holds a B.S. from James Madison University and is a member of the JMU College of Business Executive Advisory Council. Mr. Major was selected to serve as a director because of his valuable perspective and experience as President, Chief Executive Officer and a co-founder of the Company, as well as his leadership skills, industry expertise and knowledge and dedication to our mission.
Follow Eric Major:
About K2M: K2M Group Holdings is a medical device company focused on designing, developing and commercializing spine technologies and techniques.
Nick Lane
Vice President of Human Resources of Sarah Cannon
Follow Nick Lane:
About Sarah Cannon: Sarah Cannon offers integrated cancer services with convenient access to cutting-edge therapies.
Josh Stein
President & Cofounder & Board Member of AdhereTech
Josh Stein is the CEO and Cofounder of AdhereTech, a company that makes smart patented pill bottles to improve medication adherence and patient engagement. He was recently named one of the “People to Know – 2013” by the American Diabetes Associations’ Diabetes Forecast magazine. He has also been a featured speaker at a number of conferences, including TEDMED, Stanford Medicine X, Health 2.0, The Wharton Health Care Business Conference, and more.
Follow Josh Stein:
About AdhereTech: Smart devices and digital support that connect patients to care, with clinically-proven results
Mark Cockett
Vice President, Head of Discovery of ViiV Healthcare
Currently lead for the ViiV Healthcare discovery organisation, Mark Cockett is responsible for delivering new HIV drug candidates that are aligned to future medical needs into clinical development; and providing research support for clinical development assets as they progress in the clinic. Mark joined ViiV Healthcare in February this year with the acquisition of Bristol-Myers Squibb (BMS) HIV pipeline assets. Previously Mark was VP of Discovery Infectious Diseases at BMS (2008-2016), responsible for delivery of antiviral therapeutics into the pipeline. His team at BMS has delivered marketed products targeting HIV, HBV and HCV as well as the pipeline of HIV drugs recently acquired by ViiV Healthcare. Prior to this at BMS Mark was VP, Applied Genomics (2003-2008) and Executive Director, Functional Genomics (2000-2003) and in those roles led a team that supported all therapeutic areas with genomics technologies and bioinformatics. Before joining BMS, Mark worked for 7 years in the Neuroscience group at Wyeth, ultimately as Director, molecular & cell biology, and for 10 years in the biotech industry for Celltech PLC, where he worked on mammalian gene expression technology and in oncology. Whilst at Celltech he obtained his Ph.D. in collaboration with the Strangeway Research Laboratory, Cambridge, UK working on the involvement of matrix metalloproteinases in tumour cell invasion.
Follow Mark Cockett:
About ViiV Healthcare: ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE)
Harvey Masonson
Senior Vice President, Clinical Development of IVERIC bio
Harvey Masonson, M.D., joined GenSight in January 2018 in New York. Harvey is a Board-certified ophthalmologist with extensive and varied experience in the pharmaceutical industry in clinical research and clinical safety (Phases 1 to 4). He is highly skilled at clinical development planning, protocol design, study conduct, analyses, reporting and publication of pre-registration and post-marketing trials. He has demonstrated success in clinical development programs culminating in NDA approval with a track record of production of clinical documents for FDA and EMDA submission from IND application/annual reports, NDA summaries (ISE/ISS/SCS) and safety updates. His experience also includes work on various preclinical, manufacturing, statistical, regulatory and marketing issues, with a strong background in utilization and management of CROs. He was a key manager at Eyetech, OSI as well as Ophthotech (SVP). He received his undergraduate degree from the University of Rochester, magna cum laude, and his M.D. from Mt. Sinai School of Medicine. He completed a residency in Ophthalmology at Mt. Sinai, and a fellowship in Glaucoma at New York Hospital, with additional post-graduate work at the NYU School of Business Administration.
Follow Harvey Masonson:
About IVERIC bio: IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Leonard Kellner
Chairman and President of KellBenx
Mr. Kellner was previously the President and CEO of Lenetix, a women’s health focused lab acquired by Bio-Reference Laboratories. Prior to that, Mr. Kellner pioneered and launched several genetic focused screening and diagnostic tests in the women’s health arena.
Follow Leonard Kellner:
About KellBenx: Kellbenx focuses on the development of non-invasive prenatal diagnosis for specific genetic and other heritable disorders.
Thomas Thornton
Senior Vice President of Northwell Ventures
As senior vice president of Northwell Ventures, Tom Thornton is responsible for identifying and fostering innovative ideas that enhance the growth of the health system’s clinical and nonclinical enterprises. In this role, he works with senior leadership to develop and advance clinical and nonclinical ideas, bringing them into practice and the market and building strategic partnerships and relationships within the broader regional ecosystem. Mr. Thornton manages all the Northwell innovation programs, including technology commercialization, enterprise growth and investment management. Prior to Northwell, Mr. Thornton led the Healthcare Innovation Alliance at Cleveland Clinic Innovations, a program aimed at forming multi-institutional collaborations to foster and accelerate the commercialization of medical innovations.
Follow Thomas Thornton:
About Northwell Ventures: Northwell Ventures was launched to advance medical technology and promote the development of Northwell Health enterprises.
Harout Semerjian
President and CEO of GlycoMimetics
Harout Semerjian is the President and CEO at GlycoMimetics.
Follow Harout Semerjian:
About GlycoMimetics: GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
Jay Gellert
President and Chief Executive Officer of Health Net
Mr. Gellert is president and chief executive officer of Health Net, Inc. He also is a member of the board of directors of Health Net, Inc. Mr. Gellert joined the company in 1996 as president and chief operating officer of one of Health Net’s predecessor companies, Health Systems International, Inc. (HSI). He also served on the HSI board of directors and as chairman of the board for HSI’s principal operating subsidiaries, Health Net and QualMed. Prior to joining Health Net, Mr. Gellert directed Shattuck Hammond Partners Inc.’s strategic advisory engagements in the area of integrated delivery systems development, managed care network formation and physician groups practice integration. From 1988 to 1991, Mr. Gellert was president and chief executive officer of Bay Pacific Health Corporation, a Northern California health maintenance organization (HMO). From 1985 to 1988, Mr. Gellert was senior vice president and chief operating officer for California Healthcare System. Mr. Gellert serves on several boards, including America’s Health Insurance Plans (AHIP) and Ventas, Inc. He served as chairman of AHIP from June 2008 through June 2010. In addition, Mr. Gellert is co-chair of the Provider Council of the Council for Affordable Quality Healthcare (CAQH) and was chairman of the CAQH Administrative Simplification Committee, a member of the CAQH board of directors and served on the CAQH Executive Committee from July 2000 until May 2013. Mr. Gellert holds a B.A. degree from Stanford University.
Follow Jay Gellert:
About Health Net: Health Net provides health for health plans for individuals, families, and businesses.
Fady Rizk
Founder & President of Picofemto
Mr. Rizk is the CIO of the Rizk Family Office, a single family office created after the family sold an 85 year old Healthcare business. Formerly, Mr. Rizk was the Chairman of the Board of Green Holdings Corporation, a company he formed to commercially address ongoing global environmental challenges. Prior to forming Green Holdings Corporation, Mr. Rizk was a partner at SkyBridge Capital, a $330-million hedge fund incubation platform where he was responsible for international business development. Previous to SkyBridge Capital, Mr. Rizk was the President and Portfolio Manager at Falkner Holdings, Inc., a $240-million long/short hedge fund, which he managed from its inception in February 2000 through December 2004. Mr. Rizk’s career includes positions with S.G. Cowen, a division of Société Générale Group, as a Managing Director; senior level positions at NatWest Securities both in New York and London; Wyser-Pratte & Co, with responsibility for the international risk arbitrage portfolio; and Prudential Bache Securities, where his last assignment was managing a $150-million international risk arbitrage fund under the tutelage of Guy Wyser-Pratte. Prior to Prudential Bache, Mr. Rizk participated in the management training program at the Bowery Savings Bank. Mr. Rizk holds a B.S. in Accounting and Management Information Systems from Syracuse University.
Follow Fady Rizk:
About Picofemto: Picofemto is an analytics company that develops a biomedical data analysis platform.
Ashley John Heather
Co-Founder, President of Off The Scale
Ashley John Heather is the Co-Founder and President of Off The Scale.
Follow Ashley John Heather:
About CLEARED4, Off The Scale: OffTheScale is a health platform for nutritional education, exercise classes, lifestyle change tools, and community support.
